Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;40(2):94-8.

Autologous thrombin: intraoperative production from whole blood

Vijay Kumar  1 , John R Chapman
Affiliations

Autologous thrombin: intraoperative production from whole blood

Vijay Kumar et al. J Extra Corpor Technol. 2008 Jun.

Abstract

Thrombin is routinely combined in surgical practice with a fibrinogen source to prepare fibrin sealant to promote hemostasis or with platelet concentrates to prepare platelet gels to enhance wound healing. The purpose of this study was to evaluate the robustness and reproducibility of a new sterile handheld disposable thrombin-processing device (TPD) to generate autologous human thrombin in the intraoperative setting, using whole blood as the starting source material. By using whole blood instead of plasma as the starting material, it is possible to eliminate the plasma separation step from whole blood and reduce the thrombin production time and increase its availability to the surgical team intraoperatively. Active thrombin was prepared by combining 4 mL of thrombin reagent (a mixture of calcium chloride and ethanol) to 11 mL of blood in a reaction chamber containing negatively charged particles. The whole blood, reagent and particle mixture was incubated for 25 minutes at either 18 degrees C or 24 degrees C (n = 25/group) to assess stability of the thrombin activity. The mean activity of the thrombin produced at 18 degrees C and 24 degrees C was 52 +/- 14 (n = 25) and 61 +/- 12.2 IU/mL (n = 25), respectively. The average volume of thrombin harvested from each aliquot of blood at 18 degrees C and 24 degrees C was 10 +/- 0.4 and 9 +/- 0.6 mL, respectively. The thrombin concentration generated was shown to rapidly (<5 seconds) coagulate fibrinogen concentrate and retained clotting activity for 1 hour at room temperature (18-26 degrees C) and up to 4 hours when stored on ice. The results show that the TPD is able to consistently generate high thrombin activity from human whole blood. The device offers a robust and rapid approach for preparing active thrombin from whole blood.

PubMed Disclaimer

Conflict of interest statement

The authors have reported a financial relationship with the entity whose products or services are discussed in this paper.

Figures

Figure 1.
Figure 1.
Description of TPD: a reaction chamber containing negatively charged particles, reagent port, and the thrombin harvesting port.
Figure 2.
Figure 2.
Correlation between thrombin activity and in vitro clot times with PRP (1 part thrombin + 10 parts PRP) using different blood units.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Mann KG.. Thrombin formation. Chest. 2003;124(3 Suppl):4S–10S. - PubMed
    1. Aziz O, Athanasiou T, Darzi A.. Haemostasis using a ready-to-use collagen sponge coated with activated thrombin and fibrinogen. Surg Technol Int. 2005;14:35–40. - PubMed
    1. Hashemi K, Donaldson LJ, Freeman JW, Sokhi GS, Gyde OH, Smith HV.. The use of topical thrombin to reduce wound haematoma in patients receiving low-dose heparin. Curr Med Res Opin. 1981;7:458–62. - PubMed
    1. Suzuki R, Matsuhashi M, Kuwahara T, Kase T.. Topical use of thrombin in prostatic surgery. Hinyokika Kiyo. 1986;32:1461–64. - PubMed
    1. Ofodile FA, Sadana MK.. The role of topical thrombin in skin graft-ing. J Natl Med Assoc. 1991;83:416–8. - PMC - PubMed

LinkOut - more resources